Positron-Emitting Radionuclide 89Zr: Medicinal Chemistry and in Vivo Biological Behavior Evaluation

Wen CHEN,Hong-yuan WEI,Ning LIU,Shun-zhong LUO
DOI: https://doi.org/10.7538/hhx.2017.YX.2016074
2018-01-01
Abstract:Positron-emitting radionuclide 89Zr is just emerging in recent years.It has a halflife of 78.4 h,and is especially suitable for labelling antibodies,or nanoparticles,and other carriers of long time observation.89 Zr is cheap to produce,stable in vivo,and residualizes in tumors,and importantly has high resolution of PET images,therefore it will have wide application prospect in the field of PET imaging.This paper provides a comprehensive research progress of 89Zr medicinal chemistry and in vivo biological behavior evaluation,including the production and purification of 89Zr,the solution coordination chemistry of 89Zr,new bioconjugation strategies,the preclinical imaging studies of 89Zr-based agents,and the clinical applications of 89Zr-labeled radiopharmaceuticals.
What problem does this paper attempt to address?